[Our experience in the use of a new objective pain measuring system in rheumarthropatic subjects treated with transcutaneous electroanalgesia and ultrasound].

The results were assessed in a group of 38 patients with degenerative skeletal pathologies and insertional tendinopathies who were treated with transcutaneous electroanalgesia and ultrasound therapy. For this purpose a new type of painmeter was used and proved appropriate for the more rational and objective quantification of pain at precise trigger points. The case series also revealed that the best clinical response came from T.E.N.S. treatment followed by some 20 days later by a cycle of ultrasound therapy.